Cite
APA Citation
Merle, P., Rimassa, L., Ryoo, B., Cicin, I., Harris, W., Banu, E., Sarker, D., Tan, B., Van Vlierberghe, H., Sen, S., Love, C., Cheng, A., Meyer, T., Kelley, R., & Abou-Alfa, G. (n.d.). o-011Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095519247.0x000031